References
- Hou W, Zhang W, Jin R, et al. Risk factors for disease progression in hospitalized patients with COVID-19: a restrospective cohort study. Infect Dis (Lond). 2020;52(7):498–505.
- World Health Organization Coronavirus disease (COVID-19) Situation Report 111 – 10 May 2020.
- Huang R, Zhu L, Xue L, et al. Clinical findings of patients with coronavirus disease 2019. PLoS Negl Trop Dis. 2020;14(5):e0008280.
- Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. DOI:10.1001/jamainternmed.2020.0994
- Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–539.
- Qin C, Zhou L, Hu Z, Zhang S, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;ciaa248. DOI:10.1093/cid/ciaa248
- Liu Z, Long W, Tu M, et al. Lymphocyte subset (CD4+, CD8+) counts reflects the severity of infection and predict the clinical outcomes in patients with COVID-19. J Infect. 2020;S0163-4453(20)30182–1. DOI:10.1016/j.jinf.2020.03.054
- Wan S, Yi Q, Fan S, et al. Relationships among lymphocyte subsets, cytokines and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol. 2020; 189(3):428–437.
- Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020; 221(11):1762–1769.